Clinical Trial Update: Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a new thickened extensively hydrolyzed formula for infants with cow milk allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Allergy

Drugs mentioned

• New Thickened Extensively Hydrolyzed Formula (extensively hydrolyzed formula (thickened))

Snippet

Sponsor: United Pharmaceuticals | Conditions: Cow Milk Allergy | Phase 3 | Status: COMPLETED